Loading...

AVIR ATEA PHARMACEUTICALS INC Management Changes 8-K Filing

T PH

VR

ATEA PHARMACEUTICALS INC

(AVIR)

2025 8-K

Show Summary

Show Summary

Financial Statements

Board Nomination Update

Director Nominations

Financial Results

Director Appointment

Preliminary Financials

Financial Results

Earnings Report

Annual Meeting Voting Results

Earnings Report

Earnings Report

Earnings Reports

Earnings Report

Bylaws Amendment and Annual...

Earnings Report

Earnings Reports

External Links:

On April 16, 2025, Atea Pharmaceuticals entered an agreement with Radoff-JEC Signatories, resulting in the appointment of Howard H. Berman as a Class III director and the retirement of Franklin Berger in 2027; on April 17, 2025, they reported $425.4

AI Assistant

ATEA PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.